Dr. Lal Pathlabs Share Price Hits Fresh 52-Week High at Rs 1,911: Key Reasons Behind the Rally

Published: 17 September 2026 at 9:18 AM IST

Dr. Lal Pathlabs Share Price moved to Rs 1,897 on 17 September 2026, up Rs 3 or 0.16% from the previous close, after touching a fresh 52-week high of Rs 1,910.50 during the session. The company’s market capitalisation stands at Rs 31,975.2 crore. This Dr. Lal Pathlabs Share Price update is relevant because the stock reached a new yearly high even as the day’s gain remained modest, which keeps the move fact-based rather than exaggerated. The supplied data confirms the price event, while it does not establish a company-specific catalyst. For readers tracking Dr. Lal Pathlabs Stock News, the key takeaway is that price action, valuation and sector context all matter in this fresh 52-week high setup. Univest is covering the event with a focus on verified numbers and market structure.

The latest Dr. Lal Pathlabs Share Price Today movement also places the stock close to its session high, with an opening price of Rs 1,896.65 and a low of Rs 1,888. The stock has therefore traded in a relatively tight range around the new one-year high. In a market where 52 Week High Stocks often enter shortlists for stock analysis, this move puts Dr. Lal Pathlabs Share Price News on investor screens without implying any cause beyond the supplied data. Univest looks at the move through price, valuation and healthcare-sector comparisons rather than assumptions.

For those following Dr. Lal Pathlabs Share Price Live, the important context is that the stock now sits above its 200-day average of Rs 1,635.32, while it remains below the 50-day average of Rs 1,912.42. That combination helps frame the move within a broader share price update, but the session data itself should still be read as a fresh 52-week high event first and foremost. Univest therefore treats this as a verified market milestone, not a forecast.

Dr. Lal Pathlabs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,897
Previous Close	Rs 1,894
Today's Move	+Rs 3 (+0.16%)
Open	Rs 1,896.65
High	Rs 1,910.5
Low	Rs 1,888
Turnover	Rs 0.07 crore
Market Capitalisation	Rs 31,975.2 crore

Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,897 versus the previous close of Rs 1,894, a rise of 0.16%. The stock opened at Rs 1,896.65, reached a high of Rs 1,910.5 and touched a low of Rs 1,888.

The Dr. Lal Pathlabs Share Price Today action shows a rise from Rs 1,894 to Rs 1,897, with the stock touching an intraday high of Rs 1,910.50 and an intraday low of Rs 1,888. The opening price of Rs 1,896.65 was close to the previous close, which makes the day’s movement look measured rather than sharp. Turnover stood at Rs 0.07 crore, reflecting the value transacted in the session data supplied here. For readers scanning Dr. Lal Pathlabs Share Price News Today, the verified fact is simple: the stock marked a fresh 52-week high and held near that level through the session.

This kind of Dr. Lal Pathlabs Share Price Update matters because it combines a yearly high with a narrow trading band on the day. The distance between the session low and high was Rs 22.50, and the stock finished just below the peak at Rs 1,897. In stock market today searches, that pattern is often enough to place a counter among stocks in news and market movers, but the article should remain anchored to what is supplied. Univest is highlighting the event because the 52-week high itself is the factual headline, while the day’s move shows how close the close was to the session peak.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 31,975.2 crore
P/E Ratio	58.67x
P/B Ratio	12.17x
ROE	22.37%
ROCE	29.56%
EPS	Rs 32.29
Book Value Per Share	Rs 155.67
Dividend Yield	1.08%

Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P/E 58.67x, P/B 12.17x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.

Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 31975.2 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 58.67x, P/B at 12.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 46.22x, median ROE of 13.07%, median ROCE of 15.86%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	58.67x
Benchmark Median P/E	46.22x
Benchmark Average P/E	100.3x
Benchmark P/E Range	7.36x to 1,593x
Company P/B Ratio	12.17x
Benchmark Median P/B	3.75x
Company ROE	22.37%
Benchmark Median ROE	13.07%
Company ROCE	29.56%
Benchmark Median ROCE	15.86%
Company Market Capitalisation	Rs 31,975.2 crore
Benchmark Median Market Cap	Rs 476.58 crore

Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 58.67x, which is above the benchmark median of 46.22x, a difference of +26.94%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.07%, a difference of +71.16%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.86%, a difference of +86.38%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Krishna Institute of Medical Sciences Ltd	KIMS	32,204	157.77	8.52	11.04	11.51
Global Health Ltd.	MEDANTA	38,068.21	67.92	9.19	15.12	19.38
Narayana Hrudayalaya Ltd.	NH	38,754.98	46.37	7.97	19.86	16.2
DR AGARWALS HEALTH CARE L	AGARWALEYE	15,935.32	107.88	7.74	8.69	16.14
Aster DM Healthcare Ltd.	ASTERDM	64,704.25	202.67	15.27	13.07	16.22

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 58.67x compared with the displayed peer median of 107.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 31,975.2 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Dr. Lal Pathlabs

• Dr. Lal Pathlabs Share Price touched a fresh 52-week high of Rs 1,910.50 and last traded at Rs 1,897.
• The day change was Rs 3, or 0.16%, against the previous close of Rs 1,894.
• Market capitalisation stands at Rs 31,975.2 crore, placing the company above the industry median market cap.
• P/E is 58.67, P/B is 12.17, ROE is 22.37% and ROCE is 29.56%.
• Revenue and net profit both moved higher in the latest annual periods supplied.

About Dr. Lal Pathlabs

Dr. Lal Pathlabs Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The supplied data identifies it as a listed company on NSE and BSE under the symbol LALPATHLAB. Its recent financial indicators include revenue, net profit, EPS, book value and dividend yield, which together provide a factual company profile for readers tracking Dr. Lal Pathlabs Company News and Dr. Lal Pathlabs Latest News.

For investors following Dr. Lal Pathlabs Share Price and Dr. Lal Pathlabs Share Price Today, the company’s profile is best understood through the numbers provided here: market capitalisation, profitability, valuation and sector comparison. Univest presents the facts as a share price update rather than a narrative built on assumptions. That approach helps keep Dr. Lal Pathlabs Stock News grounded in verified data.

Track Dr. Lal Pathlabs Share Price on Univest

Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Dr. Lal Pathlabs Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels, sector context and stock analysis. Univest also brings together Dr. Lal Pathlabs Share Price Today, Dr. Lal Pathlabs Share News and the latest company metrics in one place for easier review.

For users comparing Dr. Lal Pathlabs Stock News with broader healthcare-sector movements, Univest provides a structured view of valuation, return ratios and peer data. That makes it easier to follow Dr. Lal Pathlabs Share Price Live without relying on scattered market snippets. Univest keeps the coverage factual, current and event-led.

Frequently Asked Questions

Why did Dr. Lal Pathlabs Share Price hit a fresh 52-week high?

Ans. The supplied data confirms that Dr. Lal Pathlabs Share Price touched Rs 1,910.50, a fresh 52-week high. It does not establish a company-specific catalyst, so the event should be read as verified price action only.

What is Dr. Lal Pathlabs Share Price today?

Ans. Dr. Lal Pathlabs Share Price last traded at Rs 1,897, up Rs 3 or 0.16% from the previous close of Rs 1,894. The stock also touched Rs 1,910.50 during the session.

What is the market capitalisation of Dr. Lal Pathlabs?

Ans. Dr. Lal Pathlabs has a market capitalisation of Rs 31,975.2 crore. That places the company well above the same-industry benchmark median market cap of Rs 476.58 crore in the supplied healthcare dataset.

How does Dr. Lal Pathlabs compare on valuation?

Ans. Dr. Lal Pathlabs trades at a P/E of 58.67 and a P/B of 12.17. Both sit above the sector medians of 46.22 and 3.75, respectively, within the supplied Hospital & Healthcare Services benchmark.

What do Dr. Lal Pathlabs ROE and ROCE show?

Ans. ROE is 22.37% and ROCE is 29.56%. Both are above the benchmark medians of 13.07% and 15.86%, which gives the stock a stronger return profile than many peers in the supplied set.

What is Dr. Lal Pathlabs EPS and book value?

Ans. EPS is 32.29 and book value is Rs 155.67. EPS reflects earnings per share, while book value shows the accounting net worth behind each share. Both help frame the share price in financial terms.

What is Dr. Lal Pathlabs dividend yield?

Ans. The supplied dividend yield is 1.08%. It is a current yield metric and should be read together with price, valuation and financial results rather than as a guaranteed future payout.

How does Dr. Lal Pathlabs compare with peers?

Ans. Dr. Lal Pathlabs’ P/E is lower than several peers such as KIMS, MEDANTA and Aster DM Healthcare, while its ROE and ROCE are stronger than many names in the supplied peer set. That is the main comparison takeaway.